Thomas J McKearn's Net Worth
$196 Thousand
Who is Thomas J McKearn?
Thomas J McKearn does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Advaxis, Inc., and Onconova Therapeutics, Inc..
SEC CIK
Thomas J McKearn's CIK is 0001022849
Past Insider Trading and Trends
2013 was Thomas J McKearn's most active year for acquiring shares with 7 total transactions. Thomas J McKearn's most active month to acquire stocks was the month of October. 2016 was Thomas J McKearn's most active year for disposing of shares, totalling 3 transactions. Thomas J McKearn's most active month to dispose stocks was the month of February. 2013 saw Thomas J McKearn paying a total of $99,993.65 for 1,873,975 shares, this is the most they've acquired in one year. In 2016 Thomas J McKearn cashed out on 30,416 shares for a total of $245,558.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Advaxis, Inc. (ADXS) Snapshot price: $0.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| -15.00% | -12.32K |
$8.08 | -$99,513.28 | 69.8K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
| -4.76% | -4.10K |
$7.45 | -$30,545.00 | 82.12K |
May 13
| |||
Form 4
| -13.97% | -14.00K |
$8.25 | -$115,500.00 | 86.22K |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
| +17.60% | 15K |
—
|
—
| 100.22K |
Mar 30
| |||
Form 4
| +15.90% | 11.69K |
$3.04 | -$40,808.96 | 85.22K |
Nov 3
| |||
Form 4
| +212.50% | 50K |
—
|
—
| 73.53K |
Jul 17
| |||
Form 4
| +77.98% | 10.31K |
$4.85 | $49,998.65 | 23.53K |
Nov 18
| |||
Form 4
| +452.18% | 1.35M |
—
|
—
| 1.65M |
Mar 14 - Jun 12
| |||
Form 4
| +66.93% | 120K |
—
|
—
| 299.29K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Onconova Therapeutics, Inc. (ONTX) No price found
President, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
∞
| 3.33K |
$15.00 | $49,995.00 | 3.33K |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||